about
Characterization of chronic idiopathic thrombocytopenic purpura in Japanese children: a retrospective multi-center study.Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.Novel missense mutation (R94S) in the TAZ ( G4.5) gene in a Japanese patient with Barth syndrome.2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation CollClinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.Selective apoptosis of natural killer-cell tumours by l-asparaginase.Effect of L-asparaginase combined with vincristine and prednisolone on acute myeloblastic leukemia (M0) associated with non-Hodgkin lymphoma.Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome.The incidence of colorectal cancer during pregnancy in Japan: report of two cases and review of Japanese cases.Extensive gene deletions in Japanese patients with Diamond-Blackfan anemia.Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.Clinical characteristics and outcomes of chédiak-Higashi syndrome: a nationwide survey of Japan.Rapid detection of intracellular p47phox and p67phox by flow cytometry; useful screening tests for chronic granulomatous disease.Development of new classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.Metabolic basis for differential glutamine requirements of human leukemia cell lines.Focal glucose hypermetabolism in interictal state of West syndrome.Langerhans cell histiocytosis with multifocal bone lesions: comparative clinical features between single and multi-systems.Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders.Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome.The inhibition of lymphocyte blastogenesis by asparaginase: critical role of glutamine in both T and B lymphocyte transformation.Cell cycle related change of Ara-C transport in HL-60 cells after differentiation inductionVP-16-induced nucleotide pool changes and poly(ADP-ribose) synthesis: the role of VP-16 in interphase deathSuccessful bone marrow transplantation from an HLA-identical unrelated donor in a patient with hemophagocytic lymphohistiocytosisA novel missense mutation in the DKC1 gene in a Japanese family with X-linked dyskeratosis congenitaA child with myeloid/natural killer cell precursor acute leukemia treated successfully with acute myeloid leukemia-oriented chemotherapy incorporating L-asparaginaseChildhood-onset PsA in Down syndrome with psoriasis susceptibility variant CARD14 rs11652075PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatric patients with acute leukaemia and an HLA-matched sibling donor
P50
Q33387705-29D27BEF-93A0-4F92-AE45-AF20902A1603Q36517235-49859852-75F2-4260-811B-FF05AC7D2854Q38288881-1600B252-319F-4338-BAE1-11DE95C0755AQ38575277-28CE6B34-7CAC-4B35-84AE-935E3E20760CQ38729149-037047FB-26C1-4962-A1EC-B59199AB0ABDQ40198507-CEC0F534-FBFE-4E3E-B9C8-349E67C22A34Q40374756-AFAC0C5A-C308-4907-B4C7-ED4D2548F707Q40377464-2FECBB5E-60A5-40A2-AC28-F26EE6F9B417Q41724174-2FE6AF0A-7D7E-4813-B934-DDBAFBF1949AQ41757741-4928755C-91A5-4537-BD87-0505C5F62DCEQ43601891-34A47065-0A61-4B15-B537-0E8333292513Q44883993-D8FD3216-1949-4722-9F1F-95D8C4FFC633Q45164810-6F7AD983-610C-45C1-B2CF-0DDCA2FFF729Q45353388-F7FB91FE-C981-4649-9EBC-F898A9F3DD5FQ45840736-923663D6-C953-4085-9A60-6DAA9229C26BQ46045382-BD93D762-6443-4E64-AD21-ED4DB9652212Q46866857-8466AE48-17DE-4074-A0EA-7181E9AC223FQ53369244-EF59A2B7-C2E6-4BEE-9721-3B00AC9F26A0Q53586239-A20D8A03-0A79-4799-85F0-405182A5AADBQ54494977-23D86E3D-A623-40D7-9C2F-97E65D666B9DQ54668490-959CCA36-C5D7-4F3C-862D-6816AF7A3A2EQ69194568-AF83ABBF-6236-4ADA-8103-70214A0A6397Q69242955-1EDE6A16-3C53-4585-BF65-BAB6ECEF0BC1Q73261977-14FF91C7-028C-42FD-BE2E-E6B639A3223AQ74626956-359433F8-A85E-46BF-9C65-BE8C4315655CQ84574753-01F2FCD2-B4DC-4276-9931-357523339346Q85849275-340D11E1-8E1F-458C-A40B-A2776F33EAC4Q86434690-7186A761-682F-4696-B1AE-883012D60B4C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Toshiyuki Kitoh
@ast
Toshiyuki Kitoh
@en
Toshiyuki Kitoh
@es
Toshiyuki Kitoh
@nl
Toshiyuki Kitoh
@sl
type
label
Toshiyuki Kitoh
@ast
Toshiyuki Kitoh
@en
Toshiyuki Kitoh
@es
Toshiyuki Kitoh
@nl
Toshiyuki Kitoh
@sl
prefLabel
Toshiyuki Kitoh
@ast
Toshiyuki Kitoh
@en
Toshiyuki Kitoh
@es
Toshiyuki Kitoh
@nl
Toshiyuki Kitoh
@sl
P1053
F-8962-2010
P106
P21
P31
P3829
P496
0000-0002-5519-8320
P569
2000-01-01T00:00:00Z